ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

Glaxo Public brae

THE proposal submitted by Glaxo Laboratories (India) for the dilution of the non resident interest in its equity capital to 40 per cent has received the approval of the Controller of Capital Issues. Glaxo Group Ltd, UK, will disinvest 28,00,000 equity shares of Rs 10 each held by them to financial institutions (24,00,000 shares) and to directors and employees (4,00,000

Dear reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top